Clinical Research Pharmacists are specialized healthcare professionals who bridge the gap between pharmaceutical science and clinical research. They play a crucial role in the planning and execution of clinical trials involving investigational drugs. Their responsibilities include evaluating drug protocols for appropriate dosing, potential interactions, and monitoring safety parameters. By collaborating closely with clinical investigators, research coordinators, and regulatory bodies, these pharmacists ensure that trial designs are scientifically sound and patient safety is prioritized. Their deep understanding of pharmacokinetics and pharmacodynamics supports accurate interpretation of clinical data, which is essential for determining a drug’s efficacy and safety profile.
In addition to protocol assessment, Clinical Research Pharmacists oversee the handling, storage, and dispensing of investigational medications according to strict regulatory and Good Clinical Practice (GCP) standards. They maintain precise drug accountability records and ensure compliance with all documentation requirements. Furthermore, they provide education and guidance to healthcare teams and patients regarding investigational drugs, side effect management, and adherence to study procedures. Their dual expertise in pharmacy and clinical research makes them indispensable for maintaining the quality and integrity of clinical trials, ultimately facilitating the development of new, safe, and effective therapeutic options for patients worldwide. As clinical research continues to evolve, their role remains critical in advancing innovative treatments.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia